Simvastatin and lovastatin suppressed expression of CDK1, CDK2, CDK3, CDK4, and CDK6 in prostate cancer cells with reduced cell viability due to induced apoptosis and cell cycle arrest (67). Here, CDK6 is linked to prostate carcinoma.